Oramed Pharmaceuticals (ORMP) Other Working Capital Changes (2010 - 2026)
Oramed Pharmaceuticals (ORMP) reported Other Working Capital Changes of -$431000.0 for Q1 2026, up 35.38% on a YoY basis from -$318357.7 in Q1 2025, and down 114.38% quarter-over-quarter from $3.0 million in Q4 2025.
Oramed Pharmaceuticals (ORMP) Other Working Capital Changes (2010 - 2026) Analysis & Trends
Oramed Pharmaceuticals has reported Other Working Capital Changes for 17 years, with the latest figure at -$431000.0 in Q1 2026.
- For the quarter ending Q1 2026, Other Working Capital Changes rose 35.38% year-over-year to -$431000.0; the trailing twelve-month figure through Mar 2026 stood at $1.2 million (up 548.73% YoY), and the FY2025 full-year result was $998000.0, up 400.14% from the prior year.
- Other Working Capital Changes for Q1 2026 stood at -$431000.0, down from $3.0 million in the prior quarter.
- The five-year high for Other Working Capital Changes was $3.0 million in Q4 2025, with the low at -$1.3 million in Q2 2023.
- Historically, Other Working Capital Changes has averaged $14250.0 across 5 years, with a median of $15000.0 in 2023.
- The largest YoY upside for Other Working Capital Changes was 814.02% in 2025 against a maximum downside of 4265.62% in 2025.
- Oramed Pharmaceuticals' Other Working Capital Changes stood at $331000.0 in 2022, then jumped by 121.75% to $734000.0 in 2023, then slumped by 55.31% to $328000.0 in 2024, then surged by 814.02% to $3.0 million in 2025, then tumbled by 114.38% to -$431000.0 in 2026.
- The last three Other Working Capital Changes figures came in at -$431000.0 (Q1 2026), $3.0 million (Q4 2025), and -$1.3 million (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - |
| 10 | Oramed Pharmaceuticals | 151.47 Mn | 133.31 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -431,000.00 |
| Mar 31, 2026 | -431,000.00 |
| Dec 31, 2025 | 3.00 Mn |
| Dec 31, 2025 | 3.00 Mn |
| Jun 30, 2025 | -1.33 Mn |
| Jun 30, 2025 | -1.33 Mn |
| Mar 31, 2025 | -667,000.00 |
| Mar 31, 2025 | -667,000.00 |
| Dec 31, 2024 | 328,000.00 |
| Dec 31, 2024 | 328,000.00 |
| Sep 30, 2024 | 32,000.00 |
| Sep 30, 2024 | 32,000.00 |
| Jun 30, 2024 | 32,000.00 |
| Jun 30, 2024 | 32,000.00 |
| Mar 31, 2024 | -36,000.00 |
| Mar 31, 2024 | -36,000.00 |
| Dec 31, 2023 | 734,000.00 |
| Dec 31, 2023 | 734,000.00 |
| Sep 30, 2023 | 614,000.00 |
| Sep 30, 2023 | 614,000.00 |